SMS Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

231.55

-11.35 (-4.67%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

231.55

-11.35 (-4.67%)
15:47 Dec 20

Quality

95/100
High Financial Strength

Valuation

47/100
Mid Valuation

Technical

40/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	563.18	519.87	522.05	709.26	768.48
Operating Expenses +	442.07	405.54	467.54	592.64	640.87
Raw Material	313.27	387.95	299.73	425.26	495.96
Increase Decrease in Cost	26.73	-112.5	36.08	-1	-40.36
Other Manufacturing Expense	39.39	55.04	57.31	73.44	0
Employee Cost	41.17	51.02	55.04	64.15	68.95
Miscellaneous Expenses	21.51	24.03	19.38	30.79	116.32
Operating Profit	121.11	114.33	54.51	116.62	127.61
Other Income	3.45	5.2	4.89	4.46	5.81
Depreciation	22.28	32.15	32.13	31.52	32.93
Interest	11.16	18.88	21.92	23.46	20.84
Profit before tax and exceptio..	91.12	68.5	5.35	66.11	79.65
Exceptional Items	0	0	0	0	0
PBT	91.12	68.5	5.35	66.11	79.65
Provision for Taxation	30.16	0.62	1.46	16.91	21.07
Net Profit	60.96	67.88	3.88	49.2	58.57
NET Profit after MI	62.53	62.22	-7.06	49.83	59.34
EPS	7.39	7.35	-0.83	5.89	7.02
Operating Profit Margin (%)	21.5	21.99	10.44	16.44	16.61
Net Profit Margin (%)	11.1	11.97	-1.35	7.03	7.72

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	64.70	64.70	64.70	64.30	64.30
FII	0.50	0.20	0.20	0.60	0.60
MF	2.60	2.10	2.00	0.00	0.00
Public	32.30	33.00	33.20	35.10	35.10
Others	0.00	0.00	0.00	0.00	0.00
Others	-0.10	0.00	-0.10	0.00	0.00